3/19/2025Shanghai Breaks Ground on National Emergency Medical Center

3/19/2025These 12 Chinese Companies Are Poised to Transform CRISPR Gene-Editing...

3/19/2025China's Healthcare Sector in 2025: Anti-Corruption and Beyond (CR)

3/19/2025Severe Decline in County Market in 2024, Possible Rebound in 2025, wit...

3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/17/2025China Suspends Imports of Five APIs from Kyowa Hakko Bio's Hofu Plant

3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...

3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Recent Executive Moves

3/14/2025PharmCube's Overview and Insights into China's Pharmaceutical Market 2...

3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...

3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...

3/10/2025China to Expand Mental Health Services Nationwide: Official

3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/10/2025The Bright Future Amidst Challenges: An Outlook on China's Pharma Econ...

3/10/2025China Biopharma Tracker – February 2025 (PharmaDJ)

3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

Page:5/356 Total number of articles:10655: [First][<<] [3] [4] [5] [6] [7] [>>] [End]